Literature DB >> 26265188

Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism.

Robert Wulff1, Claudia S Leopold2.   

Abstract

In a previous study, generally lower drug release rates from RL:L55 blend coated pellets in neutral/basic release media than in acidic release media were reported. The aim of this study was to obtain information on the drug release mechanism of solid dosage forms coated with blends of Eudragit® RL (RL) and Eudragit® L-55 (L55). Swelling experiments with free films were analyzed spectroscopically and gravimetrically to identify the physicochemical cause for this release behavior. With Raman spectroscopy, the swelling of copolymer films could be monitored. IR spectroscopic investigations on RL:L55 blends immersed in media at pH 6.8 confirmed the formation of interpolyelectrolyte complexes (IPECs) that were not detectable after swelling in hydrochloric acid pH 1.2. Further investigations revealed that these IPECs decreased the extent of ion exchange between the quaternary ammonium groups of RL and the swelling media. This is presumably the reason for the previously reported decreased drug permeability of RL:L55 coatings in neutral/basic media as ion exchange is the determining factor in drug release from RL coated dosage forms. Gravimetric erosion studies confirmed that L55 was not leached out of the film blends during swelling in phosphate buffer pH 6.8. In contrast to all other investigated films, the 4:1 (RL:L55) blend showed an extensive swelling within 24 h at pH 6.8 which explains the reported sigmoidal release behavior of 4:1 blend coated pellets. These results help to understand the release behavior of RL:L55 blend coated solid dosage forms.

Entities:  

Keywords:  enteric polymethacrylate; interpolyelectrolyte complex; ion exchange; polymer blend; quaternary polymethacrylate

Mesh:

Substances:

Year:  2015        PMID: 26265188      PMCID: PMC4984893          DOI: 10.1208/s12249-015-0377-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  24 in total

1.  Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.

Authors:  R Wulff; C S Leopold
Journal:  Int J Pharm       Date:  2014-09-17       Impact factor: 5.875

2.  Bimodal release of theophylline from "seed-matrix" beads made of acrylic polymers.

Authors:  J Ly; X Y Wu
Journal:  Pharm Dev Technol       Date:  1999-05       Impact factor: 3.133

3.  Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.

Authors:  Mohamed A Alhnan; Abdul W Basit
Journal:  Eur J Pharm Sci       Date:  2010-10-13       Impact factor: 4.384

4.  The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D.

Authors:  R Bodmeier; X Guo; R E Sarabia; P F Skultety
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

5.  Modification of quaternary polymethacrylate films using sodium alginate: film characterization and drug permeability.

Authors:  Natnicha Khuathan; Thaned Pongjanyakul
Journal:  Int J Pharm       Date:  2013-11-06       Impact factor: 5.875

6.  Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.

Authors:  Rouslan I Moustafine; Evgeniya B Margulis; Liliya F Sibgatullina; Vera A Kemenova; Guy Van den Mooter
Journal:  Eur J Pharm Biopharm       Date:  2008-04-22       Impact factor: 5.571

7.  An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid.

Authors:  S Narisawa; M Nagata; Y Hirakawa; M Kobayashi; H Yoshino
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

8.  Ammonio polymethacrylate-coated diltiazem: drug release from single pellets, media dependence, and swelling behavior.

Authors:  Grant Heinicke; Joseph B Schwartz
Journal:  Pharm Dev Technol       Date:  2007       Impact factor: 3.133

9.  An organic acid-induced sigmoidal release system for oral controlled-release preparations.

Authors:  S Narisawa; M Nagata; C Danyoshi; H Yoshino; K Murata; Y Hirakawa; K Noda
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

Review 10.  Controlled release solid dosage forms using combinations of (meth)acrylate copolymers.

Authors:  Diego Gallardo; Brigitte Skalsky; Peter Kleinebudde
Journal:  Pharm Dev Technol       Date:  2008       Impact factor: 3.133

View more
  1 in total

1.  Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers.

Authors:  Pataranapa Nimtrakul; Pakawadee Sermsappasuk; Waree Tiyaboonchai
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.